Novus Nutrition Brands LLC (St. Louis), a subsidiary of Novus International Inc., has agreed to lease a dedicated R&D lab space for its Stratum Nutrition and Arenus divisions.
Novus Nutrition Brands LLC (St. Louis), a subsidiary of Novus International Inc., has agreed to lease a dedicated R&D lab space for its Stratum Nutrition and Arenus divisions.
Stratum Nutrition focuses on branded specialty and functional ingredients for foods, beverages, and dietary supplements, while Arenus produces supplements for the equine and companion animal market.
The new, separate space is located at Bio-Research & Development Growth (BRDG) Park at the Danforth Plant Science Center, located near Novus’s headquarters in St. Louis. The building features wet labs and office space. For Stratum, it will provide lab tools for conducting basic research and applications testing in food and dietary supplements.
“The presence of these labs within the BRDG Park allows us to strengthen our relationship with Danforth Plant Science Center and other companies that have a common interest in addressing the world food challenges,” said Ibrahim Abou-Nemeh, director of R&D, product discovery, for Novus International.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.